LORAH MOYE: Open Payments
NPI 1710346374 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 93 payments from 29 companies in 2025. Trend: 2023 $1,544 · 2024 $1,258 · 2025 $1,754
Food & beverage: $1,754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $221 |
| Phathom Pharmaceuticals, Inc. | 4 | $180 |
| PFIZER INC. | 9 | $169 |
| Amgen Inc. | 17 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $121 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $84 |
| Corcept Therapeutics | 2 | $48 |
Products named: VOQUEZNA, VRAYLAR, CAPLYTA, OTEZLA, FANAPT, AUSTEDO XR, XIFAXAN, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
